Home
About
FAQ
History (21)
Genomewide screen for pulmonary function in 200 families ascertained for asthma.
Predictors of Retest Effects in a Longitudinal Study of Cognitive Aging in a Diverse Community-Based Sample.
Selecting disease-modifying medications in 5q spinal muscular atrophy.
The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats.
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Biography
contributor
Principal Investigator
Time
start date
2019-09-01
end date
2023-08-31
